MicroVention announces first U.S. clinical case using aneurysm flow diverter Fred X

MicroVention today announced that the first U.S. clinical case of its flow diverter Fred X device was performed at Thomas Jefferson University Hospital in Philadelphia.

Aliso Viejo, California-based MicroVention received premarket approval for the Fred X device in September. It uses a self-expanding braided nitinol mesh to redirect blood flow and promote aneurysm occlusion. The added X technology reduces the thrombogenicity of the device material and enhances blood vessel healing.

Get the full story on our sister site, Medical Tubing + Extrusion.

Read more
  • 0